CryoLife (CRY) Stock Price, News & Analysis

Company Overview

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Key Stats

• Today's Range: N/A
• 50-Day Range: $17.19 to $21.72
• 52-Week Range: N/A
• Volume: 7,792 shs
• Average Volume: 198,221 shs
• Market Capitalization: $703.22 million
• P/E Ratio: 596.20
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CRY Stock Analysis - Frequently Asked Questions

How were CryoLife's earnings last quarter?

CryoLife, Inc. (NYSE:CRY) issued its quarterly earnings results on Thursday, November, 4th. The medical equipment provider reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.22. The medical equipment provider had revenue of $72.21 million for the quarter, compared to analysts' expectations of $72.90 million. CryoLife had a net margin of 0.63% and a trailing twelve-month return on equity of 4.24%.

Does CryoLife have any subsidiaries?

CryoLife subsidiaries include JOTEC AG, On-X Life Technologies Inc., Hemosphere, Cardiogenesis Corporation, AuraZyme Pharmaceuticals Inc., CryoLife Asia Pacific PTE. Ltd., CryoLife Canada Inc., and others.

What other stocks do shareholders of CryoLife own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CryoLife investors own include Energy Transfer (ET), Johnson & Johnson (JNJ), AT&T (T), Meta Platforms (META), Gilead Sciences (GILD), International Business Machines (IBM) and Netflix (NFLX).

Company Calendar

• Last Earnings: 11/04/2021
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:CRY
• CUSIP: 22890310
• CIK: 784199
• Web: www.cryolife.com
• Phone: (770) 419-3355
• Fax: 770-426-0031
• Employees: 1,200
• Year Founded: 1984

Profitability

• EPS (Most Recent Fiscal Year): $0.03
• Trailing P/E Ratio: 596.20
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-16,680,000.00
• Net Margins: 0.63%
• Pretax Margin: 0.41%
• Return on Equity: 4.24%
• Return on Assets: 1.63%

Debt

• Debt-to-Equity Ratio: 0.99
• Current Ratio: 4.21
• Quick Ratio: 2.93

Sales & Book Value

• Annual Sales: $253.23 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 23.30
• Book Value: $8.46 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 39,330,000
• Free Float: 37,560,000
• Market Cap: $703.22 million
• Optionable: Optionable
• Beta: 1.53